|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.310 CAD | +0.70% |
|
+2.62% | -10.58% |
| 06-26 | HLS Therapeutics Inc. - Shareholder/Analyst Call | |
| 06-23 | HLS Therapeutics to Begin its Normal Course Issuer Bid | MT |
| Market Cap | 95.33M 83.39M 76.92M 71.04M 135M 9.09B 137M 919M 361M 4.48B 358M 350M 15.4B | P/E 2026 * |
-15.2x | P/E 2027 * | -102x |
|---|---|---|---|---|---|
| Enterprise Value | 95.33M 83.39M 76.92M 71.04M 135M 9.09B 137M 919M 361M 4.48B 358M 350M 15.4B | EV / Sales 2026 * |
1.64x | EV / Sales 2027 * | 1.48x |
| Free-Float |
99.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: HLS Therapeutics Inc.
| 1 day | +0.70% | ||
| 1 week | +2.62% | ||
| Current month | -2.27% | ||
| 1 month | -1.15% | ||
| 3 months | -5.27% | ||
| 6 months | -8.30% | ||
| Current year | -10.58% |
| 1 week | 4.2 |  | 4.39 |
| 1 month | 4 | | 5.25 |
| Current year | 4 | | 5.25 |
| 1 year | 4 | | 5.76 |
| 3 years | 3 | | 7.12 |
| 5 years | 3 | | 20.52 |
| 10 years | 3 | | 25.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Millian
CEO | Chief Executive Officer | 58 | 30/04/2023 |
John Hanna
DFI | Director of Finance/CFO | 61 | 25/01/2024 |
Jason Gross
CTO | Chief Tech/Sci/R&D Officer | 61 | 31/05/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodney Hill
BRD | Director/Board Member | 58 | 11/03/2018 |
John Welborn
CHM | Chairman | 48 | 21/06/2023 |
Norma Beauchamp
BRD | Director/Board Member | 65 | 31/12/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Buy | Chief Executive Officer | 2,000 | 0.0064% | ||
| 06-15 | Buy | Chief Financial Officer | 4,000 | 0.0128% | ||
| 04-01 | Option | Director | 9,343 | 0.0299% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.70% | +2.62% | -11.32% | -35.38% | 95.33M | |
| +1.66% | +2.50% | +13.58% | +97.17% | 94.36B | |
| +0.87% | -1.31% | +46.49% | +152.00% | 55.23B | |
| +3.55% | +3.55% | +3.91% | +269.62% | 22.56B | |
| +0.37% | +0.06% | -15.11% | -23.30% | 8.01B | |
| +1.98% | -2.23% | -26.79% | -34.74% | 7.6B | |
| +0.72% | -2.26% | -11.96% | -27.99% | 6.66B | |
| -1.46% | -2.74% | +20.99% | +34.71% | 6.25B | |
| +0.81% | +1.69% | -1.69% | +23.87% | 5.36B | |
| +0.20% | +1.42% | -6.18% | -7.01% | 3.68B | |
| Average | +0.94% | -0.25% | +1.19% | +44.89% | 20.98B | |
| Weighted average by Cap. | +1.46% | +0.65% | +17.31% | +111.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 58.03M 50.76M 46.82M 43.24M 82.05M 5.53B 83.43M 559M 220M 2.73B 218M 213M 9.37B | 64.31M 56.25M 51.89M 47.92M 90.93M 6.13B 92.46M 620M 243M 3.02B 241M 236M 10.39B |
| Net income | -6.26M -5.48M -5.05M -4.67M -8.86M -597M -9.01M -60.39M -23.71M -294M -23.52M -23.01M -1.01B | -1.05M -918K -847K -782K -1.48M -100M -1.51M -10.12M -3.97M -49.33M -3.94M -3.86M -170M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | CA$4.310 | +0.70% | 30,010 |
| 09/07/26 | CA$4.280 | -0.23% | 8,400 |
| 08/07/26 | CA$4.290 | -0.23% | 6,361 |
| 07/07/26 | CA$4.300 | 0.00% | 4,900 |
| 06/07/26 | CA$4.300 | +2.38% | 20,170 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
